Environment
A pharmaceutical company that contaminates groundwater is not improving public health — it is relocating disease and calling it production. Zero liquid discharge, solar generation and a genuine reduction in packaging plastic.
A pharmaceutical company that contaminates the water table is not in the health business — it is relocating disease and attaching a margin. We reached zero liquid discharge before the regulation required it, because we could not construct an honest argument for the alternative.
This is not a values statement. It is an accounting one.
A pharmaceutical plant that discharges untreated effluent into a water table is producing disease at one end of its operation and treating it at the other. The medicine it sells is, in the most literal sense, partly cleaning up a mess the same company made. That is not a business. It is a closed loop with a margin attached.
We reached zero liquid discharge in 2024 — earlier than the regulation required and earlier than most companies our size. Not because we are unusually virtuous, but because we could not construct an honest argument for the alternative. Everything on this page follows the same logic.
“If a commitment only holds when someone is watching, it was never a commitment. It was a performance.”
Zain Ali · Chief Executive Officer
Including the years we miss the target. A sustainability report that only contains good news is a brochure.
A pharmaceutical company that contaminates groundwater is not improving public health — it is relocating disease and calling it production. Zero liquid discharge, solar generation and a genuine reduction in packaging plastic.
Free-clinic partnerships, donation programmes and a tiered pricing structure for public institutions. Access is not a campaign we run in December; it is written into how we price.
Fair wages above the statutory floor, a genuine safety record rather than a reported one, and training that treats a line operator as a professional rather than a cost centre.
An independent quality unit reporting to the board, published audit outcomes, and a whistleblower channel that does not route through the person being reported.
Our free-clinic partnership supplies chronic-disease medicine to 34 clinics across Sindh and Punjab — hypertension, diabetes and anti-infective therapy for patients who would otherwise ration doses or stop entirely.
There is no regulator checking this. No certification depends on it. It appears in no tender scoring matrix. It runs because a person with untreated hypertension in a village outside Hyderabad has the same claim on our output as anyone else, and the only thing standing between them and the medicine is a distribution decision we are entirely free to make.
Our annual sustainability report, including the targets we have missed, is available on request. If something on this page does not match what you observe, we want to hear it.